{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:30:52Z","timestamp":1789212652670,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:00:00Z","timestamp":1182470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2007,8,23]]},"DOI":"10.1007\/s10875-007-9105-z","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T09:21:18Z","timestamp":1182417678000},"page":"517-524","source":"Crossref","is-referenced-by-count":96,"title":["Primary Immunodeficiency Diseases in Australia and New Zealand"],"prefix":"10.1007","volume":"27","author":[{"given":"Philippa","family":"Kirkpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Riminton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,22]]},"reference":[{"key":"9105_CR1","first-page":"1","volume":"53","author":"ML Lindegren","year":"2004","unstructured":"Lindegren ML, Kobrynski L, Rasmussen SA, Moore CA, Grosse SD, Vanderford ML, et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. Morb Mortal Wkly Rep 2004;53:1\u201329.","journal-title":"Morb Mortal Wkly Rep"},{"key":"9105_CR2","unstructured":"European Commission. Consensus report and recommendations. in: Proceedings of the European Primary Immunodeficiencies Consensus Conference, Langen, Germany; 2006."},{"key":"9105_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2005.12.1347","volume":"117","author":"L Notarangelo","year":"2006","unstructured":"Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2006;117:883\u201396.","journal-title":"J Allergy Clin Immunol"},{"key":"9105_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0091-6749(97)70257-4","volume":"100","author":"KW Baumgart","year":"1997","unstructured":"Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol 1997;100:415\u201323.","journal-title":"J Allergy Clin Immunol"},{"key":"9105_CR5","unstructured":"Australian Bureau of Statistics. Australian Demographic Statistics: 3101.0; June 2006."},{"key":"9105_CR6","unstructured":"Statistics New Zealand. National Population Estimates; June 2006."},{"key":"9105_CR7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2249.1999.00898.x","volume":"116","author":"J Aittoniemi","year":"1999","unstructured":"Aittoniemi J, Koskinen S, Laippala P, Laine S, Miettinen A. The significance of IgG subclass deficiency and mannan-binding lectin (MBL) for susceptibility to infection in apparently healthy adults with IgA deficiency. Clin Exp Immunol 1999;116:505\u20138.","journal-title":"Clin Exp Immunol"},{"key":"9105_CR8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005;94:S1\u201363.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9105_CR9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nri1713","volume":"5","author":"C Cunningham-Rundles","year":"2005","unstructured":"Cunningham-Rundles C, Ponda PP. Molecular defects in T- and B-cell primary immunodeficiency diseases. Nat Rev Immunol 2005;5:880\u201392.","journal-title":"Nat Rev Immunol"},{"key":"9105_CR10","unstructured":"Australasian Society of Clinical Immunology and Allergy. Clinical Immunology and Allergy Workforce Survey; 2007."},{"key":"9105_CR11","first-page":"93","volume":"30","author":"P Roche","year":"2006","unstructured":"Roche P. Tuberculosis notifications in Australia, 2004. Commun Dis Intell 2006;30:93\u2013101.","journal-title":"Commun Dis Intell"},{"key":"9105_CR12","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","volume":"117","author":"JS Orange","year":"2006","unstructured":"Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006;117:S525\u201353.","journal-title":"J Allergy Clin Immunol"},{"key":"9105_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11882-002-0067-1","volume":"2","author":"RH Buckley","year":"2002","unstructured":"Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy? Curr Allergy Asthma Rep 2002;2:356\u201360.","journal-title":"Curr Allergy Asthma Rep"},{"key":"9105_CR14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2005.03.053","volume":"116","author":"JL Casanova","year":"2005","unstructured":"Casanova JL, Fieschi C, Bustamante J, Reichenbach J, Remus N, von Bernuth H, et al. From idiopathic infectious diseases to novel primary immunodeficiencies. J Allergy Clin Immunol 2005;116:426\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"9105_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1026416017763","volume":"20","author":"A Stray-Pedersen","year":"2000","unstructured":"Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol 2000;20: 477\u201385.","journal-title":"J Clin Immunol"},{"key":"9105_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0301-0546(01)79031-3","volume":"29","author":"MJ Llambi","year":"2001","unstructured":"Llambi MJ, Etxagibel Galdos A, Matamoros N. The Spanish Registry of Primary Immunodeficiencies (REDIP). Allergol Immunopathol (Madr) 2001;29:122\u20135.","journal-title":"Allergol Immunopathol (Madr)"},{"key":"9105_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-005-0360-9","volume":"25","author":"M Abuzakouk","year":"2005","unstructured":"Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol 2005;25:73\u20137.","journal-title":"J Clin Immunol"},{"key":"9105_CR18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/humu.20412","volume":"27","author":"M Costabile","year":"2006","unstructured":"Costabile M, Quach A, Ferrante A. Molecular approaches in the diagnosis of primary immunodeficiency diseases. Hum Mutat 2006;27:1163\u201373.","journal-title":"Hum Mutat"},{"key":"9105_CR19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/95.10.655","volume":"95","author":"KM Thickett","year":"2002","unstructured":"Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. Q J Med 2002;95:655\u201362.","journal-title":"Q J Med"},{"key":"9105_CR20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jcp.2004.016204","volume":"58","author":"B Seymour","year":"2005","unstructured":"Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol 2005;58:546\u20137.","journal-title":"J Clin Pathol"},{"key":"9105_CR21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.intimp.2004.02.011","volume":"4","author":"J Gracia De","year":"2004","unstructured":"De Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004;4:745\u201353.","journal-title":"Int Immunopharmacol"},{"key":"9105_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1378\/chest.127.1.197","volume":"127","author":"M Vendrell","year":"2005","unstructured":"Vendrell M, de Gracia J, Rodrigo MJ, Cruz MJ, Alvarez A, Garcia M, et al. Antibody production deficiency with normal IgG levels in bronchiectasis of unknown aetiology. Chest 2005;127:197\u2013204.","journal-title":"Chest"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9105-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-007-9105-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9105-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:10:01Z","timestamp":1559261401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-007-9105-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,22]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,8,23]]}},"alternative-id":["9105"],"URL":"https:\/\/doi.org\/10.1007\/s10875-007-9105-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,22]]}}}